Peramivir CAS 229614-55-5 Peramivir USP/Ep/ Bp
China Peramivir CAS 229614-55-5 Peramivir USP/Ep/Bp, Find details about China Water Content 0.01%, Residue on Ignition from Peramivir CAS 229614-55-5 Peramivir USP/Ep/Bp
Basic Info.
Model NO.
jf02-1
Effect
Antidepressent
Assay
99.1%
Annul Sales
2000kg
Package
Drums
Residual Solvent
Ethanol
Sample
Free
Heavy Metal
10ppm
Capacity
2500kg
Keyword
Tartaric Acid
Residual Solvents
20ppm
Stock
2000kgs
Usage
Cometics Powder
Skin
Whitening
GMP
Yes
Other Name
3-D]Pyrimidin-4-Ylamine
Trademark
jf
Transport Package
Drun
Specification
ip
Origin
China
HS Code
2099055900
Model NO.
jf02-1
Effect
Antidepressent
Assay
99.1%
Annul Sales
2000kg
Package
Drums
Residual Solvent
Ethanol
Sample
Free
Heavy Metal
10ppm
Capacity
2500kg
Keyword
Tartaric Acid
Residual Solvents
20ppm
Stock
2000kgs
Usage
Cometics Powder
Skin
Whitening
GMP
Yes
Other Name
3-D]Pyrimidin-4-Ylamine
Trademark
jf
Transport Package
Drun
Specification
ip
Origin
China
HS Code
2099055900
Product Desciption
Peramivir CAS 229614-55-5
RAPIVAB injection is a clear, colorless, sterile, isotonic solution (200 mg per 20 mL) in glass vials fitted with rubber stoppers and royal blue flip-off seals. Each mL contains 10 mg peramivir (on an anhydrous basis) in 0.9% sodium chloride solution. The pH may have been adjusted with sodium hydroxide, USP and/or hydrochloric acid, USP. The pH is 5.5 - 8.5.
Peramivir is an antiviral agent developed by Biocryst Pharmaceuticals to treat influenza A/B. The development of peramivir has been supported by the US Department of Health and Human Services as part of the government's effort to prepare for a flu pandemic. Being an influenza virus neuraminidase inhibitor, peramivir works by preventing new viruses from emerging from infected cells. Due to the poor oral bioavailability, the oral formulation of the drug was previously abandoned by Johnson and Johnson Company. The injectable intravenous formulation of peramivir was approved by the FDA in September 2017 for the treatment of acute uncomplicated influenza to pediatric patients 2 years and older who have been symptomatic for no more than two days.
RAPIVAB injection is a clear, colorless, sterile, isotonic solution (200 mg per 20 mL) in glass vials fitted with rubber stoppers and royal blue flip-off seals. Each mL contains 10 mg peramivir (on an anhydrous basis) in 0.9% sodium chloride solution. The pH may have been adjusted with sodium hydroxide, USP and/or hydrochloric acid, USP. The pH is 5.5 - 8.5.
Peramivir is an antiviral agent developed by Biocryst Pharmaceuticals to treat influenza A/B. The development of peramivir has been supported by the US Department of Health and Human Services as part of the government's effort to prepare for a flu pandemic. Being an influenza virus neuraminidase inhibitor, peramivir works by preventing new viruses from emerging from infected cells. Due to the poor oral bioavailability, the oral formulation of the drug was previously abandoned by Johnson and Johnson Company. The injectable intravenous formulation of peramivir was approved by the FDA in September 2017 for the treatment of acute uncomplicated influenza to pediatric patients 2 years and older who have been symptomatic for no more than two days.
You Might Also Like
Triac 0-10V Dali Dimmable Recessed LED Downlight/ COB LED Ce......
GMP Factory Supply Food Grade Phycocyanin Spirulina Extract
Table Tennis Racket with Rubber + Bag Ping Pong Bat
3mh Cool Giant Fat Inflatable Cat Cartoon for Advertising
Mslfp14 17*17 Wired Box Size X-ray Digital Flat Panel Detect......
Portable Glass Shape Edge Polishing Machine
A4 A3 Paper Wrapping Machine
Stainless Steel Angle Tube Strainer
Sinchold 9220/20/45 Forged Steel Welded Crane Rail Clips
Warehouse Tent Made by Superb Tent
Thyristor Rectified CO2 MIG Mag Arc Welding Machine